The 84 rating InvestorsObserver gives to CymaBay Therapeutics Inc (CBAY) stock puts it near the top of the Healthcare sector.
In addition to scoring higher than 79 percent of stocks in the Healthcare sector, CBAY’s 84 overall rating means the stock scores better than 84 of all stocks.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 84 would rank higher than 84 percent of all stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease.
These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With CymaBay Therapeutics Inc Stock Today?
CymaBay Therapeutics Inc (CBAY) stock is trading at $5.73 as of 1:26 PM on Wednesday, Feb 3, a rise of $0.15, or 2.69% from the previous closing price of $5.58. The stock has traded between $5.62 and $5.86 so far today. Volume today is 1,042,564 compared to average volume of 1,252,868.
Click Here to get the full Stock Score Report on CymaBay Therapeutics Inc (CBAY) Stock.
